论文部分内容阅读
Triple-negative breast cancer (TNBC) is an aggressive histological subtype with more limited therapeutic strategies and poorer prognoses in clinical trials,conventional treatments like hormone therapy with drugs targeting to estrogen,progesterone and HER-2 are ineffective[1].